2018 ESC/ESH Guidelines for the management of arterial hypertension

European Heart Journal, Journal Year: 2018, Volume and Issue: 39(33), P. 3021 - 3104

Published: Aug. 25, 2018

The ESC/ESH Guidelines represent the views of ESC and ESH were produced after careful consideration scientific medical knowledge evidence available at time their dating.The are not responsible in event any contradiction, discrepancy, and/or ambiguity between other official

Language: Английский

---

Comments on ‘KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease’

Kidney International, Journal Year: 2013, Volume and Issue: 84(3), P. 622 - 623

Published: Aug. 30, 2013

Language: Английский

---

Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association

Circulation, Journal Year: 2017, Volume and Issue: 136(21)

Published: Oct. 23, 2017

Population-wide reductions in cardiovascular disease incidence and mortality have not been shared equally by African Americans. The burden of the American community remains high is a primary cause disparities life expectancy between Americans whites. objectives present scientific statement are to describe health highlight unique considerations for prevention management.The sources information were identified with PubMed/Medline online from Centers Disease Control Prevention.The higher prevalence traditional risk factors (eg, hypertension, diabetes mellitus, obesity, atherosclerotic risk) underlies relatively earlier age onset diseases among Hypertension particular highly prevalent contributes directly notable stroke, heart failure, peripheral artery Despite availability effective pharmacotherapies indications some tailored failure medications), management less Americans, yielding mortality. Explanations these persistent multifactorial span individual level social environment.The strategies needed promote equity require input broad set stakeholders, including clinicians researchers across multiple disciplines.

Language: Английский

---

Chronic kidney disease

The Lancet, Journal Year: 2021, Volume and Issue: 398(10302), P. 786 - 802

Published: June 24, 2021

Language: Английский

---

Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward

Kidney International, Journal Year: 2013, Volume and Issue: 85(1), P. 49 - 61

Published: Nov. 27, 2013

Language: Английский

---

Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary

Endocrine Practice, Journal Year: 2020, Volume and Issue: 26(1), P. 107 - 139

Published: Jan. 1, 2020

Language: Английский

---

American Association Of Clinical Endocrinologists And American College Of Endocrinology -Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan – 2015

Endocrine Practice, Journal Year: 2015, Volume and Issue: 21, P. 1 - 87

Published: April 1, 2015

Language: Английский

---

Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial

The Lancet Diabetes & Endocrinology, Journal Year: 2018, Volume and Issue: 6(8), P. 605 - 617

Published: June 14, 2018

Language: Английский

---

Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary

Endocrine Practice, Journal Year: 2018, Volume and Issue: 24(1), P. 91 - 121

Published: Jan. 1, 2018

Language: Английский

---

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

New England Journal of Medicine, Journal Year: 2024, Volume and Issue: 391(2), P. 109 - 121

Published: May 24, 2024

Patients with type 2 diabetes and chronic kidney disease are at high risk for failure, cardiovascular events, death. Whether treatment semaglutide would mitigate these risks is unknown.

Language: Английский

---